STEP 1
Biobank Construction
- Older adults, average age 71
- Blood & muscle tissue
- 2-hospital multicenter cohort

Biomarker discovery powered by an aging-cohort biobankFrom sarcopenia data to diagnostics and drug discovery
Explore our pipeline
Increasing muscle mass has not yet proven how it translates into better muscle quality.
B2B R&DThe world's first multicenter sarcopenia cohort (Wonju Severance · Kangbuk Samsung)
R&DBiomarkers discovered in-house, biomarker-driven BB-SAR-001–010
B2H DIAGNOSTICSAI diagnostic support software for sarcopenia (GMP · ISO 13485) Class II medical device confirmatory trial underway
B2C HEALTHCAREBiact, Easy Rest, Nyrex, and Bibone tablets Non-reimbursed prescriptions through 30+ partner clinics
In-House
Joint Research

